These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25015939)
1. Analysis of outcomes following autologous stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during first complete remission. Kato H; Kawase T; Kako S; Mizuta S; Kurokawa M; Mori T; Ohashi K; Iwato K; Miyamura K; Hidaka M; Sakamaki H; Suzuki R; Morishima Y; Tanaka J; Haematologica; 2014 Nov; 99(11):e228-30. PubMed ID: 25015939 [No Abstract] [Full Text] [Related]
2. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission]. Takeuchi J Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763 [No Abstract] [Full Text] [Related]
3. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion. Czyz A; Lewandowski K; Kroll R; Komarnicki M Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746 [TBL] [Abstract][Full Text] [Related]
4. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups. Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425 [TBL] [Abstract][Full Text] [Related]
5. Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis. Wei H; Kuang P; Liu T Ann Hematol; 2020 Nov; 99(11):2619-2628. PubMed ID: 32960314 [TBL] [Abstract][Full Text] [Related]
6. Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. Patel B; Kirkland KE; Szydlo R; Pearce RM; Clark RE; Craddock C; Liakopoulou E; Fielding AK; Mackinnon S; Olavarria E; Potter MN; Russell NH; Shaw BE; Cook G; Goldstone AH; Marks DI Haematologica; 2009 Oct; 94(10):1399-406. PubMed ID: 19648167 [TBL] [Abstract][Full Text] [Related]
7. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Fielding AK Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039 [TBL] [Abstract][Full Text] [Related]
8. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD? Aldoss I; Pullarkat V Bone Marrow Transplant; 2019 Jan; 54(1):3-5. PubMed ID: 30446742 [No Abstract] [Full Text] [Related]
9. [Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in the first complete remission]. Nagafuji K Rinsho Ketsueki; 2023; 64(9):1144-1151. PubMed ID: 37899194 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733 [No Abstract] [Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease. Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208 [TBL] [Abstract][Full Text] [Related]
12. Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. Othman T; Li S; Zhang J; Pourhassan H; Agrawal V; Ngo D; Chen J; Farol L; Sahebi F; Sandhu K; Spielberger R; Marcucci G; Forman SJ; Stein AS; Nakamura R; Pullarkat V; Mei M; Aldoss I; Koller P Am J Hematol; 2024 Aug; 99(8):1636-1639. PubMed ID: 38800943 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562 [TBL] [Abstract][Full Text] [Related]
14. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Marks DI; Wang T; Pérez WS; Antin JH; Copelan E; Gale RP; George B; Gupta V; Halter J; Khoury HJ; Klumpp TR; Lazarus HM; Lewis VA; McCarthy P; Rizzieri DA; Sabloff M; Szer J; Tallman MS; Weisdorf DJ Blood; 2010 Jul; 116(3):366-74. PubMed ID: 20404137 [TBL] [Abstract][Full Text] [Related]
15. Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. Giebel S; Labopin M; Potter M; Poiré X; Sengeloev H; Socié G; Huynh A; Afanasyev BV; Schanz U; Ringden O; Kalhs P; Beelen DW; Campos AM; Masszi T; Canaani J; Mohty M; Nagler A Eur J Cancer; 2018 Jun; 96():73-81. PubMed ID: 29679774 [TBL] [Abstract][Full Text] [Related]
16. The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation. Marinescu EC; Bumbea H; Iordan I; Dumitru I; Soare D; Ciufu C; Gaman M Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109629 [TBL] [Abstract][Full Text] [Related]
17. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia. Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120 [TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance). Wetzler M; Watson D; Stock W; Koval G; Mulkey FA; Hoke EE; McCarty JM; Blum WG; Powell BL; Marcucci G; Bloomfield CD; Linker CA; Larson RA Haematologica; 2014 Jan; 99(1):111-5. PubMed ID: 24077846 [TBL] [Abstract][Full Text] [Related]
19. [Outcome of autologous hematopoietic stem cell transplantation in combination with imatinib for 16 cases of Philadelphia chromosome positive acute lymphoblastic leukemia]. Liu X; Jiang E; Huang Y; Yang D; Pang A; Wei J; Ma Q; Zhang R; Qiu L; Feng S; Han M Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):250-2. PubMed ID: 24666497 [No Abstract] [Full Text] [Related]
20. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study]. Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]